{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:36:05Z","timestamp":1779302165675,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["CS-2015-15-003"],"award-info":[{"award-number":["CS-2015-15-003"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020333","name":"Guerbet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/4\/34221"],"award-info":[{"award-number":["AA\/18\/4\/34221"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR 203308"],"award-info":[{"award-number":["NIHR 203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myocardial fibrosis is an important adverse prognostic marker, however; determinants of myocardial fibrosis in immune-mediated inflammatory diseases (IMIDs) remain poorly defined. We aimed to identify determinants of myocardial fibrosis in patients with IMIDs, as measured by cardiovascular magnetic resonance (CMR) extracellular volume (ECV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cross-sectional study of 116 patients with IMIDs undergoing clinical CMR at Manchester University NHS Foundation Trust. IMIDs included rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis (SSc), ankylosing spondylitis, psoriatic arthritis and vasculitis. CMR included pre- and post-contrast T1 mapping to measure myocardial ECV, with same day blood sampling. Determinants of ECV were investigated with univariable and multivariable linear regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ECV varied significantly according to IMID diagnosis (ANOVA F statistic 2.80,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.015); ECV was higher in patients with SSc compared to other IMIDs. Major determinants of ECV as a continuous variable were SSc, smoking and body mass index (BMI); regression coefficients 3.33 (95% confidence interval 0.82\u20135.84), 3.08 (0.73\u20135.43), and \u2212\u20090.19 (-0.29 \u2013 -0.09) respectively,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01 (SSc, smoking and lower BMI were associated with increased ECV). Approximately a quarter of the variability in ECV could be explained by these predictors (optimism adjusted R\n                      <jats:sup>2<\/jats:sup>\n                      0.265).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SSc is associated with a higher burden of myocardial fibrosis compared to other IMIDs. In patients with IMIDs, independent determinants of myocardial fibrosis were presence of SSc, smoking and BMI. Importantly, participants underwent CMR for clinical indications and may not be representative of IMID populations in the community.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42358-025-00451-w","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T05:44:08Z","timestamp":1749879848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseases"],"prefix":"10.1186","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0089-6180","authenticated-orcid":false,"given":"Nicholas","family":"Black","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-7392","authenticated-orcid":false,"given":"Joshua","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2030-9761","authenticated-orcid":false,"given":"Fardad","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9241-2410","authenticated-orcid":false,"given":"John P.","family":"Farrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8980-8924","authenticated-orcid":false,"given":"Josephine H.","family":"Naish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8514-0261","authenticated-orcid":false,"given":"Matthias","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8962-5642","authenticated-orcid":false,"given":"Maya H.","family":"Buch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-7088","authenticated-orcid":false,"given":"Christopher A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"issue":"7","key":"451_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","volume":"385","author":"G Schett","year":"2021","unstructured":"Schett G, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med. 2021;385(7):628\u201339. https:\/\/doi.org\/10.1056\/NEJMra1909094.","journal-title":"N Engl J Med"},{"key":"451_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3899\/jrheum.091461","volume":"85","author":"H El-Gabalawy","year":"2010","unstructured":"El-Gabalawy H, Guenther LC, Bernstein CN. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J Rhuematol. 2010;85:2. https:\/\/doi.org\/10.3899\/jrheum.091461.","journal-title":"J Rhuematol"},{"issue":"1","key":"451_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/heartjnl-2019-316378","volume":"108","author":"R Agca","year":"2022","unstructured":"Agca R, Smulders Y, Nurmohamed M. Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice. Heart. 2022;108(1):73. https:\/\/doi.org\/10.1136\/heartjnl-2019-316378.","journal-title":"Heart"},{"issue":"35","key":"451_CR4","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","volume":"38","author":"ALP Caforio","year":"2017","unstructured":"Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European society of cardiology working group on myocardial and pericardial disease. Eur Heart J. 2017;38(35):2649\u201362. https:\/\/doi.org\/10.1093\/eurheartj\/ehx321.","journal-title":"Eur Heart J"},{"issue":"10","key":"451_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/heartjnl-2016-310667","volume":"103","author":"PS Biesbroek","year":"2017","unstructured":"Biesbroek PS, Heslinga SC, Konings TC, van der Horst-Bruinsma IE, Hofman MBM, van de Ven PM, et al. Insights into cardiac involvement in ankylosing spondylitis from cardiovascular magnetic resonance. Heart. 2017;103(10):745. https:\/\/doi.org\/10.1136\/heartjnl-2016-310667.","journal-title":"Heart"},{"issue":"2","key":"451_CR6","doi-asserted-by":"publisher","first-page":"e1621","DOI":"10.1016\/j.crad.2020.09.023","volume":"76","author":"V Bordonaro","year":"2021","unstructured":"Bordonaro V, Bivort D, Dresselaers T, De Langhe E, Bogaert J, Symons R. Myocardial T1 mapping and extracellular volume quantification as novel biomarkers in risk stratification of patients with systemic sclerosis. Clin Radiol. 2021;76(2):e1621\u20138. https:\/\/doi.org\/10.1016\/j.crad.2020.09.023.","journal-title":"Clin Radiol"},{"issue":"12","key":"451_CR7","doi-asserted-by":"publisher","first-page":"e0244282","DOI":"10.1371\/journal.pone.0244282","volume":"15","author":"N Galea","year":"2020","unstructured":"Galea N, Rosato E, Gigante A, Borrazzo C, Fiorelli A, Barchetti G, et al. Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: a cardiovascular magnetic resonance study with cold pressor test. PLoS ONE. 2020;15(12):e0244282. https:\/\/doi.org\/10.1371\/journal.pone.0244282.","journal-title":"PLoS ONE"},{"issue":"1","key":"451_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12968-016-0315-5","volume":"19","author":"S Greulich","year":"2017","unstructured":"Greulich S, Mayr A, Kitterer D, Latus J, Henes J, Steubing H, et al. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides. J Cardiovasc Magn Reson. 2017;19(1):6. https:\/\/doi.org\/10.1186\/s12968-016-0315-5.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"9","key":"451_CR9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/acr.23138","volume":"69","author":"H Kobayashi","year":"2017","unstructured":"Kobayashi H, Kobayashi Y, Yokoe I, Akashi Y, Takei M, Giles JT. Magnetic resonance Imaging-Detected myocardial inflammation and fibrosis in rheumatoid arthritis: associations with disease characteristics and N-Terminal Pro-Brain natriuretic peptide levels. Arthritis Care Res (Hoboken). 2017;69(9):1304\u201311. https:\/\/doi.org\/10.1002\/acr.23138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"451_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2013.11.059","volume":"171","author":"S Mavrogeni","year":"2014","unstructured":"Mavrogeni S, Sfikakis PP, Karabela G, Stavropoulos E, Spiliotis G, Gialafos E, et al. Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch block. Int J Cardiol. 2014;171(1):82\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.059.","journal-title":"Int J Cardiol"},{"key":"451_CR11","doi-asserted-by":"publisher","unstructured":"Robinson AA, Chow K, Salerno M. Myocardial T1 and ECV measurement: underlying concepts and technical considerations. JACC: Cardiovasc Imaging. 2019;12(11, Part 2):2332\u201344. https:\/\/doi.org\/10.1016\/j.jcmg.2019.06.031.","DOI":"10.1016\/j.jcmg.2019.06.031"},{"key":"451_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.06.015","author":"A Kidambi","year":"2017","unstructured":"Kidambi A, Motwani M, Uddin A, Ripley DP, McDiarmid AK, Swoboda PP, et al. JACC: cardiovasc imaging. 2017;10(9):989\u201399. https:\/\/doi.org\/10.1016\/j.jcmg.2016.06.015. Myocardial Extracellular Volume Estimation by CMR Predicts Functional Recovery Following Acute MI."},{"issue":"1","key":"451_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12968-018-0477-4","volume":"20","author":"C Roy","year":"2018","unstructured":"Roy C, Slimani A, de Meester C, Amzulescu M, Pasquet A, Vancraeynest D, et al. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction. J Cardiovasc Magn Reson. 2018;20(1):55. https:\/\/doi.org\/10.1186\/s12968-018-0477-4.","journal-title":"J Cardiovasc Magn Reson"},{"key":"451_CR14","doi-asserted-by":"publisher","unstructured":"Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR, et al. Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc. 2015;4(12). https:\/\/doi.org\/10.1161\/jaha.115.002613.","DOI":"10.1161\/jaha.115.002613"},{"issue":"6","key":"451_CR15","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1093\/rheumatology\/keaa742","volume":"60","author":"RB Dumitru","year":"2021","unstructured":"Dumitru RB, Bissell LA, Erhayiem B, Fent G, Kidambi A, Swoboda P, et al. Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis. Rheumatology (Oxford). 2021;60(6):2934\u201345. https:\/\/doi.org\/10.1093\/rheumatology\/keaa742.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"451_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inf"},{"key":"451_CR17","doi-asserted-by":"publisher","unstructured":"Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the society for cardiovascular magnetic resonance (SCMR) endorsed by the European association for cardiovascular imagi. J Cardiovasc Magn Reson. 2017;19(1). https:\/\/doi.org\/10.1186\/s12968-017-0389-8.","DOI":"10.1186\/s12968-017-0389-8"},{"issue":"1","key":"451_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","volume":"22","author":"J Schulz-Menger","year":"2020","unstructured":"Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance\u2013\u20092020 update: society for cardiovascular magnetic resonance (SCMR): board of trustees task force on standardized Post-Processing. J Cardiovasc Magn Reson. 2020;22(1):19. https:\/\/doi.org\/10.1186\/s12968-020-00610-6.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11","key":"451_CR19","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jcmg.2020.04.026","volume":"13","author":"F Fr\u00f6jdh","year":"2020","unstructured":"Fr\u00f6jdh F, Fridman Y, Bering P, Sayeed A, Maanja M, Niklasson L, et al. Extracellular volume and global longitudinal strain both associate with outcomes but correlate minimally. JACC Cardiovasc Imaging. 2020;13(11):2343\u201354. https:\/\/doi.org\/10.1016\/j.jcmg.2020.04.026.","journal-title":"JACC Cardiovasc Imaging"},{"key":"451_CR20","doi-asserted-by":"crossref","unstructured":"Van Buuren S. Flexible imputation of missing data. CRC; 2018.","DOI":"10.1201\/9780429492259"},{"issue":"1","key":"451_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2288-9-57","volume":"9","author":"A Marshall","year":"2009","unstructured":"Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009;9(1):57. https:\/\/doi.org\/10.1186\/1471-2288-9-57.","journal-title":"BMC Med Res Methodol"},{"key":"451_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987."},{"issue":"1","key":"451_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/acr.22181","volume":"66","author":"S Mavrogeni","year":"2014","unstructured":"Mavrogeni S, Sfikakis PP, Gialafos E, Bratis K, Karabela G, Stavropoulos E, et al. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res. 2014;66(1):104\u201312. https:\/\/doi.org\/10.1002\/acr.22181.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"451_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1161\/CIRCIMAGING.112.000192","volume":"6","author":"CA Miller","year":"2013","unstructured":"Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6(3):373\u201383. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.000192.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"451_CR25","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1016\/j.jcmg.2019.04.025","volume":"12","author":"EB Schelbert","year":"2019","unstructured":"Schelbert EB, Butler J, Diez J. Why clinicians should care about the cardiac interstitium. JACC: Cardiovasc Imaging. 2019;12(11):2305\u201318. https:\/\/doi.org\/10.1016\/j.jcmg.2019.04.025.","journal-title":"JACC: Cardiovasc Imaging"},{"issue":"11","key":"451_CR26","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/annrheumdis-2020-217653","volume":"79","author":"S Plein","year":"2020","unstructured":"Plein S, Erhayiem B, Fent G, Horton S, Dumitru RB, Andrews J, et al. Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naive, early rheumatoid arthritis. Ann Rheum Dis. 2020;79(11):1414\u201322. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217653.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"451_CR27","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3899\/jrheum.170770","volume":"45","author":"W Bradham","year":"2018","unstructured":"Bradham W, Ormseth MJ, Elumogo C, Palanisamy S, Liu CY, Lawson MA, et al. Absence of fibrosis and inflammation by cardiac magnetic resonance imaging in rheumatoid arthritis patients with low to moderate disease activity. J Rheumatol. 2018;45(8):1078\u201384. https:\/\/doi.org\/10.3899\/jrheum.170770.","journal-title":"J Rheumatol"},{"key":"451_CR28","doi-asserted-by":"publisher","unstructured":"Malczuk E, Tlustochowicz W, Kramarz E, Kisiel B, Marczak M, Tlustochowicz M, et al. Early myocardial changes in patients with rheumatoid arthritis without known cardiovascular diseases-A comprehensive cardiac magnetic resonance study. Diagnostics (Basel). 2021;11(12). https:\/\/doi.org\/10.3390\/diagnostics11122290.","DOI":"10.3390\/diagnostics11122290"},{"key":"451_CR29","doi-asserted-by":"publisher","unstructured":"Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD et al. (2014). Diffuse myocardial fibrosis is subclinical and is associated with impaired myocardial deformation characteristics in systemic lupus erythematosus: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 16(Suppl 1):P307. https:\/\/doi.org\/10.1186\/532-429X-16-S1-P307. eCollection 2014.","DOI":"10.1186\/532-429X-16-S1-P307"},{"key":"451_CR30","doi-asserted-by":"publisher","unstructured":"Markousis-Mavrogenis G, Bonou M, Vartela V, Kolovou G, Venetsanopoulou A, Markatseli T, et al. Cardiovascular magnetic resonance detects inflammatory cardiomyopathy in symptomatic patients with inflammatory joint diseases and a normal routine workup. J Clin Med. 2022;11(5). https:\/\/doi.org\/10.3390\/jcm11051428.","DOI":"10.3390\/jcm11051428"},{"issue":"3","key":"451_CR31","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10554-020-02066-2","volume":"37","author":"A Giollo","year":"2021","unstructured":"Giollo A, Dumitru RB, Swoboda PP, Plein S, Greenwood JP, Buch MH, et al. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis. Int J Cardiovasc Imaging. 2021;37(3):1053\u201362. https:\/\/doi.org\/10.1007\/s10554-020-02066-2.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"1","key":"451_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1532-429X-16-21","volume":"16","author":"NAB Ntusi","year":"2014","unstructured":"Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Rai ABS, Matthews PM, et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis \u2013 a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson. 2014;16(1):21. https:\/\/doi.org\/10.1186\/1532-429X-16-21.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"451_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/rheumatology\/keu350","volume":"54","author":"TS Rodr\u00edguez-Reyna","year":"2015","unstructured":"Rodr\u00edguez-Reyna TS, Morelos-Guzman M, Hern\u00e1ndez-Reyes P, Montero-Duarte K, Mart\u00ednez-Reyes C, Reyes-Utrera C, et al. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology. 2015;54(4):647\u201354. https:\/\/doi.org\/10.1093\/rheumatology\/keu350.","journal-title":"Rheumatology"},{"issue":"12","key":"451_CR34","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1136\/ard.2008.095836","volume":"68","author":"AL Hachulla","year":"2009","unstructured":"Hachulla AL, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis. 2009;68(12):1878. https:\/\/doi.org\/10.1136\/ard.2008.095836.","journal-title":"Ann Rheum Dis"},{"key":"451_CR35","doi-asserted-by":"publisher","unstructured":"Dumitru RB, Bissell LA, Erhayiem B, Kidambi A, Dumitru AH, Fent G, et al. Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers. RMD Open. 2021;7(3). https:\/\/doi.org\/10.1136\/rmdopen-2021-001689.","DOI":"10.1136\/rmdopen-2021-001689"},{"issue":"8","key":"451_CR36","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/rheumatology\/kez494","volume":"59","author":"S Mavrogeni","year":"2019","unstructured":"Mavrogeni S, Gargani L, Pepe A, Monti L, Markousis-Mavrogenis G, De Santis M, et al. Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the scleroderma arrhythmia clinical utility study (SAnCtUS). Rheumatology. 2019;59(8):1938\u201348. https:\/\/doi.org\/10.1093\/rheumatology\/kez494.","journal-title":"Rheumatology"},{"issue":"6","key":"451_CR37","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/ehjci\/jex190","volume":"19","author":"C Storz","year":"2018","unstructured":"Storz C, Hetterich H, Lorbeer R, Heber SD, Schafnitzel A, Patscheider H, et al. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population. Eur Heart J Cardiovasc Imaging. 2018;19(6):701\u20138. https:\/\/doi.org\/10.1093\/ehjci\/jex190.","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"2","key":"451_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/ehjci\/jey140","volume":"20","author":"B Ambale-Venkatesh","year":"2019","unstructured":"Ambale-Venkatesh B, Liu C-Y, Liu Y-C, Donekal S, Ohyama Y, Sharma RK, et al. Association of myocardial fibrosis and cardiovascular events: the multi-ethnic study of atherosclerosis. Eur Heart J Cardiovasc Imaging. 2019;20(2):168\u201376. https:\/\/doi.org\/10.1093\/ehjci\/jey140.","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"4","key":"451_CR39","doi-asserted-by":"publisher","first-page":"H934","DOI":"10.1152\/ajpheart.00238.2018","volume":"315","author":"L Alex","year":"2018","unstructured":"Alex L, Russo I, Holoborodko V, Frangogiannis NG. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2018;315(4):H934\u201349. https:\/\/doi.org\/10.1152\/ajpheart.00238.2018.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"451_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.trsl.2014.05.001","volume":"164","author":"M Cavalera","year":"2014","unstructured":"Cavalera M, Wang J, Frangogiannis NG. Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl Res. 2014;164(4):323\u201335. https:\/\/doi.org\/10.1016\/j.trsl.2014.05.001.","journal-title":"Transl Res"},{"issue":"1","key":"451_CR41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/01.cir.90.1.479","volume":"90","author":"A Khaidar","year":"1994","unstructured":"Khaidar A, Marx M, Lubec B, Lubec G. L-arginine reduces heart collagen accumulation in the diabetic Db\/db mouse. Circulation. 1994;90(1):479\u201383. https:\/\/doi.org\/10.1161\/01.cir.90.1.479.","journal-title":"Circulation"},{"issue":"25","key":"451_CR42","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1016\/j.jacc.2017.10.044","volume":"70","author":"CY Liu","year":"2017","unstructured":"Liu CY, Heckbert SR, Lai S, Ambale-Venkatesh B, Ostovaneh MR, McClelland RL, et al. Association of elevated NT-proBNP with myocardial fibrosis in the multi-ethnic study of atherosclerosis (MESA). J Am Coll Cardiol. 2017;70(25):3102\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.044.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"451_CR43","doi-asserted-by":"publisher","first-page":"20168","DOI":"10.1038\/s41598-019-56213-4","volume":"9","author":"EY Yang","year":"2019","unstructured":"Yang EY, Khan MA, Graviss EA, Nguyen DT, Bhimaraj A, Nambi V, et al. Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes. Sci Rep. 2019;9(1):20168. https:\/\/doi.org\/10.1038\/s41598-019-56213-4.","journal-title":"Sci Rep"},{"issue":"3","key":"451_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/heartjnl-2023-322857","volume":"110","author":"J Bradley","year":"2024","unstructured":"Bradley J, Schelbert EB, Bonnett LJ, Lewis GA, Lagan J, Orsborne C, et al. Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation. Heart. 2024;110(3):195\u2013201. https:\/\/doi.org\/10.1136\/heartjnl-2023-322857.","journal-title":"Heart"},{"issue":"8","key":"451_CR45","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","volume":"27","author":"GA Lewis","year":"2021","unstructured":"Lewis GA, Dodd S, Clayton D, Bedson E, Eccleson H, Schelbert EB, et al. Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial. Nat Med. 2021;27(8):1477\u201382. https:\/\/doi.org\/10.1038\/s41591-021-01452-0.","journal-title":"Nat Med"},{"issue":"5","key":"451_CR46","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00296-020-04565-w","volume":"40","author":"N Acharya","year":"2020","unstructured":"Acharya N, Sharma SK, Mishra D, Dhooria S, Dhir V, Jain S. Efficacy and safety of Pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial. Rheumatol Int. 2020;40(5):703\u201310. https:\/\/doi.org\/10.1007\/s00296-020-04565-w.","journal-title":"Rheumatol Int"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00451-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00451-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00451-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:56:16Z","timestamp":1763369776000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00451-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00451-w","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.jcmg.2016.06.015","asserted-by":"subject"}]},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The investigation conforms with the\n                      Declaration of Helsinki.\n                      The study was approved by a NHS Research Ethics Committee, and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}